PMID: 6988957Mar 15, 1980Paper

Loss of 2 kidney grafts due to recurrence of type II membrano-proliferative glomerulonephritis

Schweizerische medizinische Wochenschrift
E P LeumannF Largiadèr

Abstract

Recurrent glomerulonephritis after renal transplantation is seen in a very high percentage of patients with dense "deposit" disease (= membrano-proliferative glomerulonephritis type II). However, loss of graft due to recurrence is rare; only 4 cases have been reported. Two additional pediatric patients are described. Both had recurrent dense "deposit" disease with extracapillary proliferation and crescent formation. In one of them, a quiet initial phase of 20 months was followed by an extremely rapid progression of the disease leading to loss of graft function within 3 weeks.

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Pediatric Nephrology : Journal of the International Pediatric Nephrology Association
Ozan OzkayaHasan Tahsin Keceligil
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
Leila BenabdallahHenri Kreis
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
Z KorzetsJ Bernheim
© 2021 Meta ULC. All rights reserved